Omnipod 5

Omnipod® 5 Shows Significant Improvements in Glycemic Measures and Diabetes Distress

Omnipod 5 is the first automated insulin delivery system (AID) FDA cleared for patients with type 2 diabetes in the US. It is also the first and only tubeless AID system in the US. A single arm, multicenter prospective study by Pasquel et al.

Brenda Ferris, MS, RD, CDCES, CDN *

March 6, 2025

Real-World Evidence of Omnipod® 5 Shows Glycemic Outcomes That Indicate Effective Use of the System in a Non-Clinical Setting

In February of 2024, Forlenza et al.

Guest Blogger

March 4, 2024

Optimizing the Omnipod® 5 Activity Feature for Your Patients

Guest Blogger

February 20, 2024

Study Shows Omnipod® 5 Improved Glycemic Measures for Patients with Type 1 Diabetes

Guest Blogger

January 10, 2024

HCP with podder paitient in yellow dress

Switching Patients from Multiple Daily Injections (MDI) to Omnipod® 5

Guest Blogger

January 5, 2024

HCP with young podder patient and parent

Switching Patients from Other Automated Insulin Delivery (AID) Systems to Omnipod® 5

Guest Blogger

January 5, 2024